Study Reveals Potential New Target for Cholesterol-Lowering Drugs
UT Southwestern Medical CenterMice lacking a key protein involved in cholesterol regulation have low-density lipoprotein, or "bad" cholesterol, levels more than 50 percent lower than normal mice, suggesting the inhibition of the same protein in humans could lead to new cholesterol-lowering drugs.